In vitro interaction of HMG-CoA reductase inhibitors (statins) with MDR1, MRP2, and OATP-C

被引：0
|
作者：
Chen, CP [1 ]
Mireles, R [1 ]
Campbell, S [1 ]
Lin, J [1 ]
Mills, J [1 ]
Xu, J [1 ]
Smolarek, T [1 ]
机构：
[1] Pfizer Inc, Groton Lab, Groton, CT 06340 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
303
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [31] Hepatobiliary elimination of the cardiac glycoside ouabain in rodents: The role of Oatp1a4, mrp2 and mdr1
    Geyer, J
    Gavrilova, O
    Petzinger, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R5 - R5
  • [32] Drug-Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors
    Chauvin, Benoit
    Drouot, Sylvain
    Barrail-Tran, Aurelie
    Taburet, Anne-Marie
    CLINICAL PHARMACOKINETICS, 2013, 52 (10) : 815 - 831
  • [33] Monitoring the cellular effects of HMG-CoA reductase inhibitors in vitro and ex vivo
    Cicha, I
    Schneiderhan-Marra, N
    Yilmaz, A
    Garlichs, CD
    Goppelt-Struebe, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) : 2046 - 2050
  • [34] Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors
    Kiener, PA
    Davis, PM
    Murray, JL
    Youssef, S
    Rankin, BM
    Kowala, MK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (01) : 105 - 118
  • [35] Benefit-risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment
    Wanishayakorn, Tanatape
    Sornlertlumvanich, Korn
    Ngorsuraches, Surachat
    BMJ OPEN, 2016, 6 (02):
  • [36] PHARMACOKINETIC INTERACTION BETWEEN PROPRANOLOL AND THE HMG-COA REDUCTASE INHIBITORS PRAVASTATIN AND LOVASTATIN
    PAN, HY
    TRISCARI, J
    DEVAULT, AR
    SMITH, SA
    WANGIVERSON, D
    SWANSON, BN
    WILLARD, DA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) : 665 - 670
  • [37] DIFFERENTIAL EFFECT OF GENETIC VARIANTS OF NTCP AND OATP1B1 ON THE UPTAKE OF HMG-CoA REDUCTASE INHIBITORS.
    Shin, H.
    Choi, Y.
    Yeo, C.
    Park, B.
    Shon, J.
    Cha, I.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S44 - S44
  • [38] HMG-CoA reductase inhibitors (statins) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity
    Aarons, CB
    Cohen, PA
    Gower, A
    Reed, KL
    Stucchi, AF
    Becker, JM
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (03) : S12 - S12
  • [39] Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity
    Aarons, Cary B.
    Cohen, Philip A.
    Gower, Adam
    Reed, Karen L.
    Leeman, Susan E.
    Stucchi, Arthur F.
    Becker, James M.
    ANNALS OF SURGERY, 2007, 245 (02) : 176 - 184
  • [40] Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors
    Park, William K. C.
    Kennedy, Robert M.
    Larsen, Scott D.
    Miller, Steve
    Roth, Bruce D.
    Song, Yuntao
    Steinbaugh, Bruce A.
    Sun, Kevin
    Tait, Bradley D.
    Kowala, Mark C.
    Trivedi, Bharat K.
    Auerbach, Bruce
    Askew, Valerie
    Dillon, Lisa
    Hanselman, Jeffrey C.
    Lin, Zhiwu
    Lu, Gina H.
    Robertson, Andrew
    Sekerke, Catherine
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 1151 - 1156
12345